Yuan Li (Hengyang, China)
Yuan Li graduated with a Master’s degree in Basic Medicine from University of South China in 2015. Since then, she has served as a clinical pharmacist in the Central Laboratory of the Third Hospital of Changsha. In 2017, Yuan Li was appointed as the Quality Management Director of the Phase I clinical Trial Center.
Yuan Li has been participated in and been responsible for the design and quality management of various clinical trials, including bioequivalence and pharmacokinetic studies, the drug categories involved include anti-infective drugs, cardiovascular drugs, and anti-tumor drugs, among others, administered via inhalation, nasal sprays, and injection. She is dedicated to clinical research and the evaluation of new drugs, as well as the clinical pharmacology of anti-infective drugs.
Yuan Li graduated with a Master’s degree in Basic Medicine from University of South China in 2015. Since then, she has served as a clinical pharmacist in the Central Laboratory of the Third Hospital of Changsha. In 2017, Yuan Li was appointed as the Quality Management Director of the Phase I clinical Trial Center.
Yuan Li has been participated in and been responsible for the design and quality management of various clinical trials, including bioequivalence and pharmacokinetic studies, the drug categories involved include anti-infective drugs, cardiovascular drugs, and anti-tumor drugs, among others, administered via inhalation, nasal sprays, and injection. She is dedicated to clinical research and the evaluation of new drugs, as well as the clinical pharmacology of anti-infective drugs.